Original Research

Published on 24 Aug 2022

Comprehensive analysis to identify a novel PTEN-associated ceRNA regulatory network as a prognostic biomarker for lung adenocarcinoma

in Cancer Molecular Targets and Therapeutics

Rui Xin
Biao Shen
Ying-Jie Jiang
Ji-Bin Liu
Sha Li
Li-Kun Hou
Wei Wu
Cheng-You Jia
Chun-Yan Wu
Da Fu

Frontiers in Oncology

doi 10.3389/fonc.2022.923026

2,857 views
1 citation

Review

Published on 23 Aug 2022

Phase separation in epigenetics and cancer stem cells

in Cancer Molecular Targets and Therapeutics

Chanchan Xiao
Guangjie Wu
Pengfei Chen
Lijuan Gao
Guobing Chen
Hongyi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.922604

4,951 views
6 citations

Brief Research Report

Published on 22 Aug 2022

Tracking fibrosis in myeloproliferative neoplasms by CCR2 expression on CD34+ cells

in Cancer Molecular Targets and Therapeutics

Giulia Pozzi
Cecilia Carubbi
Giuliana Gobbi
Sara Tagliaferri
Prisco Mirandola
Marco Vitale
Elena Masselli

Frontiers in Oncology

doi 10.3389/fonc.2022.980379

2,025 views
1 citation

Original Research

Published on 22 Aug 2022

PKIB involved in the metastasis and survival of osteosarcoma

in Cancer Molecular Targets and Therapeutics

Rongxue Wan
Gu Yang
Qianzhen Liu
Xiaokang Fu
Zengping Liu
Huilai Miao
Huan Liu
Wenhua Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.965838

2,588 views
2 citations

Original Research

Published on 18 Aug 2022

Selinexor inhibits growth of patient derived chordomas in vivo as a single agent and in combination with abemaciclib through diverse mechanisms

in Cancer Molecular Targets and Therapeutics

Christopher J. Walker
Hua Chang
Leah Henegar
Trinayan Kashyap
Sharon Shacham
Josh Sommer
Michael J. Wick
Joan Levy
Yosef Landesman

Frontiers in Oncology

doi 10.3389/fonc.2022.808021

3,335 views
3 citations

Original Research

Published on 18 Aug 2022

Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library

in Cancer Molecular Targets and Therapeutics

Jisun Oh
Hyun−Ju An
Hyun Jeong Yeo
Sujin Choi
Jisu Oh
Segi Kim
Jin Man Kim
Junwon Choi
Soonchul Lee

Frontiers in Oncology

doi 10.3389/fonc.2022.893951

5,468 views
5 citations

Original Research

Published on 17 Aug 2022

ACO1 and IREB2 downregulation confer poor prognosis and correlate with autophagy-related ferroptosis and immune infiltration in KIRC

in Cancer Molecular Targets and Therapeutics

Ting Zhu
Zhuoyu Xiao
Haoyu Yuan
Hu Tian
Taoyi Chen
Qi Chen
Mingkun Chen
Jiankun Yang
Qizhao Zhou
Wenbin Guo

Frontiers in Oncology

doi 10.3389/fonc.2022.929838

6,686 views
17 citations

Original Research

Published on 17 Aug 2022

Stellera chamaejasme L. extracts in the treatment of glioblastoma cell lines: Biological verification based on a network pharmacology approach

in Cancer Molecular Targets and Therapeutics

Kaiyue Wang
Zengyong Wang
Zhiqiang Wang
Xiaoli Xie
Lanlan Zang
Lijuan Wang
Fengyuan Che

Frontiers in Oncology

doi 10.3389/fonc.2022.962970

3,980 views
1 citation

Case Report

Published on 15 Aug 2022

Primary Ewing’s sarcoma of sphenoid sinus: A case report and literature review

in Cancer Molecular Targets and Therapeutics

Kunpeng Wu
Xiaoyan Zhu
Yan Li
Daxiong Wen
Huiyu Wu
Yanzhen Lai
Yun Li
Jian Wu
Zhuoxing Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.894833

1,645 views
1 citation

Original Research

Published on 15 Aug 2022

Fatty acid desaturase 1 (FADS1) is a cancer marker for patient survival and a potential novel target for precision cancer treatment

in Cancer Molecular Targets and Therapeutics

Gioia Heravi
Hyejeong Jang
Xiaokun Wang
Ze Long
Zheyun Peng
Seongho Kim
Wanqing Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.942798

6,051 views
14 citations

Review

Published on 12 Aug 2022

The bacteria inside human cancer cells: Mainly as cancer promoters

in Cancer Molecular Targets and Therapeutics

Wei Zhu
Jing-Zi Wang
Zhixian Liu
Ji-Fu Wei

Frontiers in Oncology

doi 10.3389/fonc.2022.897330

10,545 views
4 citations

Review

Published on 12 Aug 2022

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway

in Cancer Molecular Targets and Therapeutics

Geofrey Mahiki Mranda
Zhi-Ping Xiang
Jun-Jian Liu
Tian Wei
Yinlu Ding

Frontiers in Oncology

doi 10.3389/fonc.2022.937957

3,465 views
11 citations

Review

Published on 11 Aug 2022

The role of fascin-1 in the pathogenesis, diagnosis and management of respiratory related cancers

in Cancer Molecular Targets and Therapeutics

Naibin Zhang
Yankun Gao
Qiang Bian
Qianqian Wang
Ying Shi
Zhankui Zhao
Honglian Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.948110

2,279 views
1 citation

Original Research

Published on 11 Aug 2022

Investigational cyclin-dependent kinase 4/6 inhibitor GLR2007 demonstrates activity against isocitrate dehydrogenase wild-type glioblastoma and other solid tumors in mice xenograft models

in Cancer Molecular Targets and Therapeutics

Lei Yin
Zhenglin Yao
Yue Wang
Michelle Mazuranic

Frontiers in Oncology

doi 10.3389/fonc.2022.915862

2,738 views

Case Report

Published on 11 Aug 2022

Case report: Salvage capmatinib therapy in KIF5B-MET fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotin

in Cancer Molecular Targets and Therapeutics

Chien-Yu Lin
Sheng-Huan Wei
Yi-Lin Chen
Chung-Ta Lee
Shang-Yin Wu
Chung-Liang Ho
Dean C. Pavlick
Po-Lan Su
Chien-Chung Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.919123

2,258 views
4 citations

Original Research

Published on 10 Aug 2022

Folate-modified erythrocyte membrane nanoparticles loaded with Fe3O4 and artemisinin enhance ferroptosis of tumors by low-intensity focused ultrasound

in Cancer Molecular Targets and Therapeutics

Xingyue Wang
Peng Li
Xiangxiang Jing
Yun Zhou
Yongfu Shao
Min Zheng
Junrui Wang
Haitao Ran
Hailin Tang

Frontiers in Oncology

doi 10.3389/fonc.2022.864444

3,225 views
7 citations

Navigation group

Articles

Comprehensive analysis to identify a novel PTEN-associated ceRNA regulatory network as a prognostic biomarker for lung adenocarcinoma

Phase separation in epigenetics and cancer stem cells

Tracking fibrosis in myeloproliferative neoplasms by CCR2 expression on CD34+ cells

PKIB involved in the metastasis and survival of osteosarcoma

Selinexor inhibits growth of patient derived chordomas in vivo as a single agent and in combination with abemaciclib through diverse mechanisms

Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library

ACO1 and IREB2 downregulation confer poor prognosis and correlate with autophagy-related ferroptosis and immune infiltration in KIRC

Stellera chamaejasme L. extracts in the treatment of glioblastoma cell lines: Biological verification based on a network pharmacology approach

Primary Ewing’s sarcoma of sphenoid sinus: A case report and literature review

Fatty acid desaturase 1 (FADS1) is a cancer marker for patient survival and a potential novel target for precision cancer treatment

The bacteria inside human cancer cells: Mainly as cancer promoters

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway

The role of fascin-1 in the pathogenesis, diagnosis and management of respiratory related cancers

Investigational cyclin-dependent kinase 4/6 inhibitor GLR2007 demonstrates activity against isocitrate dehydrogenase wild-type glioblastoma and other solid tumors in mice xenograft models

Case report: Salvage capmatinib therapy in KIF5B-MET fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotin

Folate-modified erythrocyte membrane nanoparticles loaded with Fe3O4 and artemisinin enhance ferroptosis of tumors by low-intensity focused ultrasound